Table 3. Medication Management Outcomes at 12 Months by Study Groupa.
| Outcome | No. With Finding/Total No. (%) | EHR Tools Alone vs Usual Care | EHR Tools Plus Education Group, No. With Finding/Total No. (%) | EHR Tools Plus Education vs Usual Care | EHR Tools Plus Education vs EHR Tools Alone | ||||
|---|---|---|---|---|---|---|---|---|---|
| Usual Care Group | EHR Tools Alone Group | Adjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value | ||
| Medications Reconciled | |||||||||
| Hypertension medications | |||||||||
| Baseline | 91/252 (36.1) | 116/261 (44.4) | NA | NA | 141/278 (50.7) | NA | NA | NA | NA |
| 12 mo | 91/252 (36.1) | 133/261 (51.0) | 1.8 (1.1-2.9) | .01 | 154/278 (55.4) | 2.0 (1.3-3.3) | .003 | 1.1 (0.7-1.8) | .62 |
| All mediations for chronic conditions | |||||||||
| Baseline | 27/252 (10.7) | 69/261 (26.4) | NA | NA | 74/278 (26.6) | NA | NA | NA | NA |
| 12 mo | 30/252 (11.9) | 72/261 (27.6) | 2.5 (1.2-5.2) | .02 | 71/278 (25.5) | 2.5 (1.2-5.2) | .02 | 1.0 (0.5-2.0) | .98 |
| All medications | |||||||||
| Baseline | 4/252 (1.6) | 29/261 (11.1) | NA | NA | 31/278 (11.2) | NA | NA | NA | NA |
| 12 mo | 4/252 (1.6) | 18/261 (6.9) | 4.0 (0.7-22.2) | .11 | 21/278 (7.6) | 6.0 (1.1-32.3) | .04 | 1.5 (0.4-6.1) | .58 |
| Knowledge of Medication Indication | |||||||||
| Hypertension medications | |||||||||
| Baseline | 178/229 (77.7) | 186/238 (78.2) | NA | NA | 198/235 (84.3) | NA | NA | NA | NA |
| 12 mo | 194/240 (80.8) | 212/255 (83.1) | 1.3 (0.8-2.4) | .32 | 233/267 (87.3) | 1.4 (0.8-2.5) | .30 | 1.0 (0.6-1.9) | .95 |
| All medications for chronic conditions | |||||||||
| Baseline | 171/247 (69.2) | 166/253 (65.6) | NA | NA | 202/265 (76.2) | NA | NA | NA | NA |
| 12 mo | 177/250 (70.8) | 175/259 (67.6) | 1.0 (0.6-1.5) | .82 | 209/277 (75.5) | 1.1 (0.7-1.7) | .69 | 1.2 (0.7-1.8) | .53 |
| All medications | |||||||||
| Baseline | 117/254 (46.1) | 126/262 (48.1) | NA | NA | 139/277 (50.2) | NA | NA | NA | NA |
| 12 mo | 137/253 (54.2) | 149/261 (57.1) | 1.1 (0.6-2.0) | .71 | 176/277 (63.5) | 1.3 (0.7-2.4) | .34 | 1.2 (0.6-2.2) | .57 |
| Understanding of Medication Instructions and Dosing | |||||||||
| All medications for hypertension | |||||||||
| Baseline | 183/226 (81.0) | 199/235 (84.7) | NA | NA | 188/234 (80.3) | NA | NA | NA | NA |
| 12 mo | 177/238 (74.4) | 200/255 (78.4) | 1.3 (0.6-2.5) | .53 | 225/264 (85.2) | 2.3 (1.1-4.8) | .03 | 1.8 (0.9-3.9) | .11 |
| All medications for chronic conditions | |||||||||
| Baseline | 178/244 (73.0) | 188/249 (75.5) | NA | NA | 187/260 (71.9) | NA | NA | NA | NA |
| 12 mo | 158/248 (63.7) | 180/261 (69.0) | 1.2 (0.7-2.0) | .47 | 201/275 (73.1) | 1.7 (1.0-2.8) | .05 | 1.4 (0.8-2.3) | .22 |
| All medications | |||||||||
| Baseline | 154/252 (61.1) | 181/259 (69.9) | NA | NA | 178/275 (64.7) | NA | NA | NA | NA |
| 12 mo | 143/253 (56.5) | 164/261 (62.8) | 1.2 (0.7-2.0) | .54 | 186/276 (67.4) | 1.7 (1.0-2.9) | .047 | 1.5 (0.9-2.5) | .17 |
| Medication Adherence, 4-d Recall | |||||||||
| Hypertension medications | |||||||||
| Baseline | 140/229 (61.1) | 160/238 (67.2) | NA | NA | 134/236 (56.8) | NA | NA | NA | NA |
| 12 mo | 178/239 (74.5) | 189/256 (73.8) | 0.9 (0.6-1.4) | .64 | 191/267 (71.5) | 0.9 (0.6-1.4) | .59 | 1.0 (0.6-1.5) | .94 |
| All medications for chronic conditions | |||||||||
| Baseline | 132/247 (53.4) | 148/252 (58.7) | NA | NA | 124/264 (47.0) | NA | NA | NA | NA |
| 12 mo | 159/249 (63.9) | 160/261 (61.3) | 0.8 (0.6-1.2) | .34 | 164/277 (59.2) | 0.8 (0.6-1.2) | .33 | 1.0 (0.7-1.4) | .99 |
Abbreviations: EHR, electronic health record; NA, not applicable; OR, odds ratio.
a
Numbers do not always equal total number of participants in each arm in cases where no Access Community Health Network record was available (medication reconciliation), no patient-reported medications could be identified in the category, dosing instructions were not available, or owing to nonresponse. All models contain baseline values for the outcome, study group, and health center–level random effects.